Mir-487a promotes TGF-β1-induced EMT, the migration and invasion of breast cancer cells by directly targeting MAGI2

International Journal of Biological Sciences

Volumn 12, Issue 4, 2016, Pages 397-408

  Ma, Mengtao ^a   He, Miao ^a   Jiang, Qian ^a   Yan, Yuanyuan ^a   Guan, Shu ^a   Zhang, Jing ^a   Yu, Zhaojin ^a   Chen, Qiuchen ^a   Sun, Mingli ^a   Yao, Weifan ^a   Zhao, Haishan ^a   Jin, Feng ^a   Wei, Minjie ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Breast cancer; EMT; MAGI2; MiR 487a; p65; TGF 1

Indexed keywords

CARRIER PROTEIN; MAGI2 PROTEIN, HUMAN; MICRORNA; MIRN487 MICRORNA, HUMAN; TRANSFORMING GROWTH FACTOR BETA1;

DRUG EFFECTS; EPITHELIAL MESENCHYMAL TRANSITION; GENE EXPRESSION REGULATION; GENETICS; HEK293 CELL LINE; HUMAN; MCF-7 CELL LINE; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; TUMOR CELL LINE; TUMOR INVASION;

CARRIER PROTEINS; CELL LINE, TUMOR; EPITHELIAL-MESENCHYMAL TRANSITION; GENE EXPRESSION REGULATION, NEOPLASTIC; HEK293 CELLS; HUMANS; MCF-7 CELLS; MICRORNAS; NEOPLASM INVASIVENESS; TRANSFORMING GROWTH FACTOR BETA1;

EID: 84957568728     PISSN: 14492288     EISSN: None     Source Type: Journal    
DOI: 10.7150/ijbs.13475     Document Type: Article

References (33)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D: Global cancer statistics. CA: A Cancer Journal for Clinicians 2011, 61(2):69-90.
2. Thiery JP, Acloque H, Huang RYJ, Nieto MA: Epithelial-Mesenchymal Transitions in Development and Disease. Cell 2009, 139(5):871-890.
3. Ozdamar B, Bose R, Barrios-Rodiles M, Wang HR, Zhang Y, Wrana JL: Regulation of the polarity protein Par6 by TGFbeta receptors controls epithelial cell plasticity. Science 2005, 307(5715):1603-1609.
4. Ikenouchi J: Regulation of tight junctions during the epithelium-mesenchyme transition: direct repression of the gene expression of claudins/occludin by Snail. Journal of Cell Science 2003, 116(10):1959-1967.
5. Guarino M: Epithelial–mesenchymal transition and tumour invasion. The International Journal of Biochemistry & Cell Biology 2007, 39(12):2153-2160.
6. Yang J, Weinberg RA: Epithelial-Mesenchymal Transition: At the Crossroads of Development and Tumor Metastasis. Developmental Cell 2008, 14(6):818-829.
7. Xu J, Lamouille S, Derynck R: TGF-β-induced epithelial to mesenchymal transition. Cell Research 2009, 19(2):156-172.
8. Bakin AV, Tomlinson AK, Bhowmick NA, Moses HL, Arteaga CL: Phosphatidylinositol 3-Kinase Function Is Required for Transforming Growth Factor-mediated Epithelial to Mesenchymal Transition and Cell Migration. Journal of Biological Chemistry 2000, 275(47):36803-36810.
9. Chen X-F, Zhang H-J, Wang H-B, Zhu J, Zhou W-Y, Zhang H, Zhao M-C, Su J-M, Gao W, Zhang L et al: Transforming growth factor-β1 induces epithelial-to-mesenchymal transition in human lung cancer cells via PI3K/Akt and MEK/Erk1/2 signaling pathways. Molecular Biology Reports 2011, 39(4):3549-3556.
10. Korpal M, Lee ES, Hu G, Kang Y: The miR-200 Family Inhibits Epithelial-Mesenchymal Transition and Cancer Cell Migration by Direct Targeting of E-cadherin Transcriptional Repressors ZEB1 and ZEB2. Journal of Biological Chemistry 2008, 283(22):14910-14914.
11. Han X, Yan S, Weijie Z, Feng W, Liuxing W, Mengquan L, Qingxia F: Critical role of miR-10b in transforming growth factor-β1-induced epithelial–mesenchymal transition in breast cancer. Cancer Gene Therapy 2014, 21(2):60-67.
12. Cao M, Seike M, Soeno C, Mizutani H, KITAMURA K, MINEGISHI Y, NORO R, YOSHIMURA A, CAI L, GEMMA A: MiR-23a regulates TGF-β-induced epithelial-mesenchymal transition by targeting E-cadherin in lung cancer cells. International Journal of Oncology 2012.
13. Brockhausen J, Tay SS, Grzelak CA, Bertolino P, Bowen DG, d’Avigdor WM, Teoh N, Pok S, Shackel N, Gamble JR et al: miR-181a mediates TGF-β-induced hepatocyte EMT and is dysregulated in cirrhosis and hepatocellular cancer. Liver International 2015, 35(1):240-253.
14. Ma M-T, He M, Wang Y, Jiao X-Y, Zhao L, Bai X-F, Yu Z-J, Wu H-Z, Sun M-L, Song Z-G et al: MiR-487a resensitizes mitoxantrone (MX)-resistant breast cancer cells (MCF-7/MX) to MX by targeting breast cancer resistance protein (BCRP/ABCG2). Cancer Letters 2013, 339(1):107-115.
15. Neel J-C, Lebrun J-J: Activin and TGFβ regulate expression of the microRNA-181 family to promote cell migration and invasion in breast cancer cells. Cellular Signalling 2013, 25(7):1556-1566.
16. Li Y, Li W, Ying Z, Tian H, Zhu X, Li J, Li M: Metastatic heterogeneity of breast cancer cells is associated with expression of a heterogeneous TGFbeta-activating miR424-503 gene cluster. Cancer research 2014, 74(21):6107-6118.
17. Yu Z, Xiao Q, Zhao L, Ren J, Bai X, Sun M, Wu H, Liu X, Song Z, Yan Y et al: DNA methyltransferase 1/3a overexpression in sporadic breast cancer is associated with reduced expression of estrogen receptor-alpha/breast cancer susceptibility gene 1 and poor prognosis. Molecular Carcinogenesis 2014.
18. Valiente M: Binding of PTEN to Specific PDZ Domains Contributes to PTEN Protein Stability and Phosphorylation by Microtubule-associated Serine/Threonine Kinases. Journal of Biological Chemistry 2005, 280(32):28936-28943.
19. Hu Y, Li Z, Guo L, Wang L, Zhang L, Cai X, Zhao H, Zha X: MAGI-2 Inhibits cell migration and proliferation via PTEN in human hepatocarcinoma cells. Archives of Biochemistry and Biophysics 2007, 467(1):1-9.
20. Xu J, Lamouille S, Derynck R: TGF-beta-induced epithelial to mesenchymal transition. Cell research 2009, 19(2):156-172.
21. Molly A. Taylor, Khalid Sossey-Alaoui, Cheryl L. Thompson, David Danielpour, Schiemann WP: TGF-β upregulates miR-181a expressionto promote breast cancer metastasis. The Journal of Clinical Investigation 2013.
22. Gregory PA, Bracken CP, Smith E, Bert AG, Wright JA, Roslan S, Morris M, Wyatt L, Farshid G, Lim YY et al: An autocrine TGF-beta/ZEB/miR-200 signaling network regulates establishment and maintenance of epithelial-mesenchymal transition. Molecular biology of the cell 2011, 22(10):1686-1698.
23. He H, Wang L, Zhou W, Zhang Z, Xu S, Wang D, Dong J, Tang C, Tang H, Yi X et al: MicroRNA Expression Profiling in Clear Cell Renal Cell Carcinoma: Identification and Functional Validation of Key miRNAs. PloS one 2015, 10(5):e0125672.
24. Wang J, Pei YH, Zhong Y, Jiang SS, Shao JQ, Gong JB: Altered Serum MicroRNAs as Novel Diagnostic Biomarkers for Atypical Coronary Artery Disease. PloS one 2014, 9(9).
25. Chen G, Zhu W, Shi D, Lv L, Zhang C, Liu P, Hu W: MicroRNA-181a sensitizes human malignant glioma U87MG cells to radiation by targeting Bcl-2. Oncology Reports 2010, 23(4).
26. Wang Y, et al. Transforming growth factor β regulates the sphere-initiating stem cell-like feature in breast cancer through miRNA-181 and ATM. Oncogene 2011.
27. Yang C-C, Hung P-S, Wang P-W, Liu C-J, Chu T-H, Cheng H-W, Lin S-C: miR-181 as a putative biomarker for lymph-node metastasis of oral squamous cell carcinoma. J Oral Pathol Med 2011, 40:397-404.
28. Wang B, Hsu SH, Majumder S, Kutay H, Huang W, Jacob ST, Ghoshal K: TGFβ-mediated upregulation of hepatic miR-181b promotes hepatocarcinogenesis by targeting TIMP3. Oncogene 2009, 29(12):1787-1797.
29. Pons A ea: Hematopoiesis-related microRNA expression in myelodysplastic syndromes. Leuk Lymphoma 2009, 50(11):1854–1859.
30. Pichiorri F, Suh SS, Ladetto M, Kuehl M, Palumbo T, Drandi D, Taccioli C, Zanesi N, Alder H, Hagan JP et al: MicroRNAs regulate critical genes associated with multiple myeloma pathogenesis. Proceedings of the National Academy of Sciences 2008, 105(35):12885-12890.
31. Hirao K, Hata Y, Ide N, Takeuchi M, Irie M, Yao I, Deguchi M, Toyoda A, Sudhof TC, Takai Y: A Novel Multiple PDZ Domain-containing Molecule Interacting with N-Methyl-D-aspartate Receptors and Neuronal Cell Adhesion Proteins. The Journal of Biological Chemistry 1998, 273:21105–21110.
32. Kitamura K, Seike M, Okano T, Matsuda K, Miyanaga A, Mizutani H, Noro R, Minegishi Y, Kubota K, Gemma A: MiR-134/487b/655 Cluster Regulates TGF--Induced Epithelial-Mesenchymal Transition and Drug Resistance to Gefitinib by Targeting MAGI2 in Lung Adenocarcinoma Cells. Molecular Cancer Therapeutics 2013, 13(2):444-453.
33. Gong C, Qu S, Liu B, Pan S, Jiao Y, Nie Y, Su F, Liu Q, Song E: MiR-106b expression determines the proliferation paradox of TGF-beta in breast cancer cells. Oncogene 2015, 34(1):84-93.